What is the address of MEDPHYS Dr GILSON?

The registered office of MEDPHYS Dr GILSON is located at Rue Echevesnes 37, 6542 Lobbes.

Is MEDPHYS Dr GILSON still active?

Yes. According to the CBE (30 October 2026) MEDPHYS Dr GILSON is active, legal situation “Normale toestand”, started on 27 March 2014.

Is MEDPHYS Dr GILSON registered on Peppol?

No, MEDPHYS Dr GILSON is currently not registered on the Peppol network.

What is the enterprise number of MEDPHYS Dr GILSON?

The enterprise number of MEDPHYS Dr GILSON is BE0548979616.

When was MEDPHYS Dr GILSON founded?

MEDPHYS Dr GILSON was founded on 27 March 2014.

Is MEDPHYS Dr GILSON a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 March 2014; 5 annual accounts filed, latest fiscal year 2025.

How much profit did MEDPHYS Dr GILSON make in 2025?

MEDPHYS Dr GILSON posted a profit after taxes of € 58,534 in financial year 2025.

What is the revenue of MEDPHYS Dr GILSON?

As a small company, MEDPHYS Dr GILSON is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 81,769.

MEDPHYS Dr GILSON (Private Limited) - Lobbes

Dossier MEDPHYS Dr GILSON, printed on 30 October 2026 from databakkes.be/en/0548979616/medphys-dr-gilson. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MEDPHYS Dr GILSON from Lobbes, company number BE0548979616, closed financial year 2025 with a result of € 58,534 after tax. For that financial year MEDPHYS Dr GILSON recorded a gross margin of € 81,769 and equity of € 108,731. Compared with financial year 2024, the result moved from € 59,737 to € 58,534. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 4, 2026.

What it is worth Growing

€ 108,731

▲ 36% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 58,534

▼ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 131,152

▲ 26% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 30,000 paid out

51 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 594

▼ 19% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 799

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 14,177

▲ 108% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 113,319 Gross margin 2022: € 113,319 First fiscal year in the series	€ 106,886 Gross margin 2023: € 106,886 ▼ 6% vs 2022 (€ 113,319) Unfavourable step	€ 85,256 Gross margin 2024: € 85,256 ▼ 20% vs 2023 (€ 106,886) Unfavourable step	€ 81,769 Gross margin 2025: € 81,769 ▼ 4% vs 2024 (€ 85,256) Unfavourable step	▼ 4%
Profit after taxes	€ 82,311 Profit after taxes 2022: € 82,311 First fiscal year in the series	€ 82,328 Profit after taxes 2023: € 82,328 Unchanged (€ 82,311) Favourable step	€ 59,737 Profit after taxes 2024: € 59,737 ▼ 27% vs 2023 (€ 82,328) Unfavourable step	€ 58,534 Profit after taxes 2025: € 58,534 ▼ 2% vs 2024 (€ 59,737) Unfavourable step	▼ 2%
Equity	€ 20,460 Equity 2022: € 20,460 First fiscal year in the series	€ 20,460 Equity 2023: € 20,460 Unchanged (€ 20,460) Unchanged	€ 80,197 Equity 2024: € 80,197 ▲ 292% vs 2023 (€ 20,460) Favourable step	€ 108,731 Equity 2025: € 108,731 ▲ 36% vs 2024 (€ 80,197) Favourable step	▲ 36%
Total debts	€ 279,910 Total debts 2022: € 279,910 First fiscal year in the series	€ 199,603 Total debts 2023: € 199,603 ▼ 29% vs 2022 (€ 279,910) Favourable step	€ 148,655 Total debts 2024: € 148,655 ▼ 26% vs 2023 (€ 199,603) Favourable step	€ 93,591 Total debts 2025: € 93,591 ▼ 37% vs 2024 (€ 148,655) Favourable step	▼ 37%
Cash	€ 178,775 Cash 2022: € 178,775 First fiscal year in the series	€ 98,688 Cash 2023: € 98,688 ▼ 45% vs 2022 (€ 178,775) Unfavourable step	€ 104,403 Cash 2024: € 104,403 ▲ 6% vs 2023 (€ 98,688) Favourable step	€ 131,152 Cash 2025: € 131,152 ▲ 26% vs 2024 (€ 104,403) Favourable step	▲ 26%
Land & buildings	€ 728 Land & buildings 2022: € 728 First fiscal year in the series	€ 477 Land & buildings 2023: € 477 ▼ 35% vs 2022 (€ 728) Unchanged	€ 224 Land & buildings 2024: € 224 ▼ 53% vs 2023 (€ 477) Unchanged	€ 224 Land & buildings 2025: € 224 Unchanged (€ 224) Unchanged
Retained profit	€ 1,860 Retained profit 2022: € 1,860 First fiscal year in the series	€ 1,860 Retained profit 2023: € 1,860 Unchanged (€ 1,860) Unchanged	€ 61,597 Retained profit 2024: € 61,597 ▲ € 59,737 vs 2023 (€ 1,860) Favourable step	€ 90,131 Retained profit 2025: € 90,131 ▲ 46% vs 2024 (€ 61,597) Favourable step	▲ 46%
Dividend	€ 82,311 Dividend 2022: € 82,311 First fiscal year in the series	€ 82,328 Dividend 2023: € 82,328 Unchanged (€ 82,311) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 82,328) Unchanged	€ 30,000 Dividend 2025: € 30,000 Unchanged (€ 0) Unchanged
Bank debt	€ 1,127 Bank debt 2022: € 1,127 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 1,127) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 300,370 Balance sheet total 2022: € 300,370 First fiscal year in the series	€ 220,063 Balance sheet total 2023: € 220,063 ▼ 27% vs 2022 (€ 300,370) Unchanged	€ 228,853 Balance sheet total 2024: € 228,853 ▲ 4% vs 2023 (€ 220,063) Unchanged	€ 202,322 Balance sheet total 2025: € 202,322 ▼ 12% vs 2024 (€ 228,853) Unchanged	▼ 12%

Key figures of MEDPHYS Dr GILSON, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDPHYS Dr GILSON?

What happened at MEDPHYS Dr GILSON in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 4, 2026 New annual accounts for financial year 2025: profit of € 58,534 (▼ 2% vs 2024). filed late Source: NBB ↗
Mar 27, 2014 New establishment in Lobbes. KBO
Mar 27, 2014 Start of the company according to the CBE. KBO

In short

From € 82,311 profit in 2022 to € 58,534 profit in 2025.

Paid € 86,937 in corporate taxes since 2022.

Best year ever: 2023, with € 82,328 profit.

Paid out € 194,638 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Echevesnes 37

6542 Lobbes

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0548.979.616
VAT number: BE 0548.979.616
Registered office: Rue Echevesnes 37, 6542 Lobbes
Names & denominations: MEDPHYS Dr GILSON
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 March 2014
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDPHYS Dr GILSON